Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays
HH Mostafa, J Hardick, E Morehead, JA Miller… - Journal of Clinical …, 2020 - Elsevier
The SARS-CoV-2 pandemic has challenged molecular microbiology laboratories to quickly
implement and validate diagnostic assays and to expand testing capacity in a short
timeframe. Multiple molecular diagnostic methods received FDA emergency use
authorization (EUA) and were promptly validated for use nationwide. Several studies
reported the analytical and/or clinical evaluation of these molecular assays, however
differences in the viral materials used for these evaluations complicated direct comparison of …
implement and validate diagnostic assays and to expand testing capacity in a short
timeframe. Multiple molecular diagnostic methods received FDA emergency use
authorization (EUA) and were promptly validated for use nationwide. Several studies
reported the analytical and/or clinical evaluation of these molecular assays, however
differences in the viral materials used for these evaluations complicated direct comparison of …